Pulmonary Embolism Drug Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pulmonary Embolism Drug
1.2 Key Market Segments
1.2.1 Pulmonary Embolism Drug Segment by Type
1.2.2 Pulmonary Embolism Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pulmonary Embolism Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Pulmonary Embolism Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pulmonary Embolism Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pulmonary Embolism Drug Market Competitive Landscape
3.1 Global Pulmonary Embolism Drug Sales by Manufacturers (2019-2024)
3.2 Global Pulmonary Embolism Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Pulmonary Embolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pulmonary Embolism Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pulmonary Embolism Drug Sales Sites, Area Served, Product Type
3.6 Pulmonary Embolism Drug Market Competitive Situation and Trends
3.6.1 Pulmonary Embolism Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pulmonary Embolism Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pulmonary Embolism Drug Industry Chain Analysis
4.1 Pulmonary Embolism Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pulmonary Embolism Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pulmonary Embolism Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pulmonary Embolism Drug Sales Market Share by Type (2019-2024)
6.3 Global Pulmonary Embolism Drug Market Size Market Share by Type (2019-2024)
6.4 Global Pulmonary Embolism Drug Price by Type (2019-2024)
7 Pulmonary Embolism Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pulmonary Embolism Drug Market Sales by Application (2019-2024)
7.3 Global Pulmonary Embolism Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Pulmonary Embolism Drug Sales Growth Rate by Application (2019-2024)
8 Pulmonary Embolism Drug Market Segmentation by Region
8.1 Global Pulmonary Embolism Drug Sales by Region
8.1.1 Global Pulmonary Embolism Drug Sales by Region
8.1.2 Global Pulmonary Embolism Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Pulmonary Embolism Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pulmonary Embolism Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pulmonary Embolism Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pulmonary Embolism Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pulmonary Embolism Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Accu-Break Pharmaceuticals, Inc.
9.1.1 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Basic Information
9.1.2 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Product Overview
9.1.3 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Product Market Performance
9.1.4 Accu-Break Pharmaceuticals, Inc. Business Overview
9.1.5 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug SWOT Analysis
9.1.6 Accu-Break Pharmaceuticals, Inc. Recent Developments
9.2 Dong-A Socio Holdings Co. Ltd.
9.2.1 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Basic Information
9.2.2 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Product Overview
9.2.3 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Product Market Performance
9.2.4 Dong-A Socio Holdings Co. Ltd. Business Overview
9.2.5 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug SWOT Analysis
9.2.6 Dong-A Socio Holdings Co. Ltd. Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Basic Information
9.3.2 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Product Overview
9.3.3 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd. Business Overview
9.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Genentech, Inc.
9.4.1 Genentech, Inc. Pulmonary Embolism Drug Basic Information
9.4.2 Genentech, Inc. Pulmonary Embolism Drug Product Overview
9.4.3 Genentech, Inc. Pulmonary Embolism Drug Product Market Performance
9.4.4 Genentech, Inc. Business Overview
9.4.5 Genentech, Inc. Recent Developments
9.5 Verseon Corp
9.5.1 Verseon Corp Pulmonary Embolism Drug Basic Information
9.5.2 Verseon Corp Pulmonary Embolism Drug Product Overview
9.5.3 Verseon Corp Pulmonary Embolism Drug Product Market Performance
9.5.4 Verseon Corp Business Overview
9.5.5 Verseon Corp Recent Developments
10 Pulmonary Embolism Drug Market Forecast by Region
10.1 Global Pulmonary Embolism Drug Market Size Forecast
10.2 Global Pulmonary Embolism Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pulmonary Embolism Drug Market Size Forecast by Country
10.2.3 Asia Pacific Pulmonary Embolism Drug Market Size Forecast by Region
10.2.4 South America Pulmonary Embolism Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pulmonary Embolism Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pulmonary Embolism Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pulmonary Embolism Drug by Type (2025-2030)
11.1.2 Global Pulmonary Embolism Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pulmonary Embolism Drug by Type (2025-2030)
11.2 Global Pulmonary Embolism Drug Market Forecast by Application (2025-2030)
11.2.1 Global Pulmonary Embolism Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Pulmonary Embolism Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pulmonary Embolism Drug Market Size Comparison by Region (M USD)
Table 5. Global Pulmonary Embolism Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pulmonary Embolism Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pulmonary Embolism Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pulmonary Embolism Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Drug as of 2022)
Table 10. Global Market Pulmonary Embolism Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pulmonary Embolism Drug Sales Sites and Area Served
Table 12. Manufacturers Pulmonary Embolism Drug Product Type
Table 13. Global Pulmonary Embolism Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pulmonary Embolism Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pulmonary Embolism Drug Market Challenges
Table 22. Global Pulmonary Embolism Drug Sales by Type (Kilotons)
Table 23. Global Pulmonary Embolism Drug Market Size by Type (M USD)
Table 24. Global Pulmonary Embolism Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pulmonary Embolism Drug Sales Market Share by Type (2019-2024)
Table 26. Global Pulmonary Embolism Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Pulmonary Embolism Drug Market Size Share by Type (2019-2024)
Table 28. Global Pulmonary Embolism Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pulmonary Embolism Drug Sales (Kilotons) by Application
Table 30. Global Pulmonary Embolism Drug Market Size by Application
Table 31. Global Pulmonary Embolism Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pulmonary Embolism Drug Sales Market Share by Application (2019-2024)
Table 33. Global Pulmonary Embolism Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Pulmonary Embolism Drug Market Share by Application (2019-2024)
Table 35. Global Pulmonary Embolism Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Pulmonary Embolism Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pulmonary Embolism Drug Sales Market Share by Region (2019-2024)
Table 38. North America Pulmonary Embolism Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pulmonary Embolism Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pulmonary Embolism Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pulmonary Embolism Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pulmonary Embolism Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Basic Information
Table 44. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Product Overview
Table 45. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Accu-Break Pharmaceuticals, Inc. Business Overview
Table 47. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug SWOT Analysis
Table 48. Accu-Break Pharmaceuticals, Inc. Recent Developments
Table 49. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Basic Information
Table 50. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Product Overview
Table 51. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Dong-A Socio Holdings Co. Ltd. Business Overview
Table 53. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug SWOT Analysis
Table 54. Dong-A Socio Holdings Co. Ltd. Recent Developments
Table 55. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Basic Information
Table 56. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Product Overview
Table 57. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd. Business Overview
Table 60. F. Hoffmann-La Roche Ltd. Recent Developments
Table 61. Genentech, Inc. Pulmonary Embolism Drug Basic Information
Table 62. Genentech, Inc. Pulmonary Embolism Drug Product Overview
Table 63. Genentech, Inc. Pulmonary Embolism Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Genentech, Inc. Business Overview
Table 65. Genentech, Inc. Recent Developments
Table 66. Verseon Corp Pulmonary Embolism Drug Basic Information
Table 67. Verseon Corp Pulmonary Embolism Drug Product Overview
Table 68. Verseon Corp Pulmonary Embolism Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Verseon Corp Business Overview
Table 70. Verseon Corp Recent Developments
Table 71. Global Pulmonary Embolism Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Pulmonary Embolism Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Pulmonary Embolism Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Pulmonary Embolism Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Pulmonary Embolism Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Pulmonary Embolism Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Pulmonary Embolism Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Pulmonary Embolism Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Pulmonary Embolism Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Pulmonary Embolism Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Pulmonary Embolism Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Pulmonary Embolism Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Pulmonary Embolism Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Pulmonary Embolism Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Pulmonary Embolism Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Pulmonary Embolism Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Pulmonary Embolism Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pulmonary Embolism Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pulmonary Embolism Drug Market Size (M USD), 2019-2030
Figure 5. Global Pulmonary Embolism Drug Market Size (M USD) (2019-2030)
Figure 6. Global Pulmonary Embolism Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pulmonary Embolism Drug Market Size by Country (M USD)
Figure 11. Pulmonary Embolism Drug Sales Share by Manufacturers in 2023
Figure 12. Global Pulmonary Embolism Drug Revenue Share by Manufacturers in 2023
Figure 13. Pulmonary Embolism Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pulmonary Embolism Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pulmonary Embolism Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pulmonary Embolism Drug Market Share by Type
Figure 18. Sales Market Share of Pulmonary Embolism Drug by Type (2019-2024)
Figure 19. Sales Market Share of Pulmonary Embolism Drug by Type in 2023
Figure 20. Market Size Share of Pulmonary Embolism Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Pulmonary Embolism Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pulmonary Embolism Drug Market Share by Application
Figure 24. Global Pulmonary Embolism Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Pulmonary Embolism Drug Sales Market Share by Application in 2023
Figure 26. Global Pulmonary Embolism Drug Market Share by Application (2019-2024)
Figure 27. Global Pulmonary Embolism Drug Market Share by Application in 2023
Figure 28. Global Pulmonary Embolism Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pulmonary Embolism Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pulmonary Embolism Drug Sales Market Share by Country in 2023
Figure 32. U.S. Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pulmonary Embolism Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pulmonary Embolism Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pulmonary Embolism Drug Sales Market Share by Country in 2023
Figure 37. Germany Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pulmonary Embolism Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pulmonary Embolism Drug Sales Market Share by Region in 2023
Figure 44. China Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pulmonary Embolism Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Pulmonary Embolism Drug Sales Market Share by Country in 2023
Figure 51. Brazil Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pulmonary Embolism Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pulmonary Embolism Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pulmonary Embolism Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pulmonary Embolism Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pulmonary Embolism Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pulmonary Embolism Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pulmonary Embolism Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Pulmonary Embolism Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Pulmonary Embolism Drug Market Share Forecast by Application (2025-2030)
Industry Market Size
